Credit rating agency CRISIL has revised its rating outlook on the long-term bank facilities of Poly Medicure to ‘Positive’ from ‘Stable’ while reaffirming the rating at ‘A’. The rating agency has also reaffirmed ‘A1’ rating to the company’s short-term bank facilities.
The outlook revision reflects that the company may continue to demonstrate healthy growth in operating revenue on the back of capacity addition on account of its new plant in Jaipur (Rajasthan); the plant commenced operations in May 2014.
Poly Medicure manufactures disposable medical items, such as intravenous cannulae, blood bags, blood storage tubes, and infusion and transfusion sets.
